Mmcap International Inc. Spc Cardiol Therapeutics Inc. Transaction History
Mmcap International Inc. Spc
- $329 Million
- Q4 2024
A detailed history of Mmcap International Inc. Spc transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Mmcap International Inc. Spc holds 795,625 shares of CRDL stock, worth $867,231. This represents 0.31% of its overall portfolio holdings.
Number of Shares
795,625
Previous 795,625
-0.0%
Holding current value
$867,231
Previous $1.58 Million
34.86%
% of portfolio
0.31%
Previous 0.36%
Shares
8 transactions
Others Institutions Holding CRDL
# of Institutions
43Shares Held
7.63MCall Options Held
4.9KPut Options Held
3.8K-
Tejara Capital LTD London, X03.12MShares$3.4 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD882KShares$961,9110.23% of portfolio
-
Pvg Asset Management Corp Golden, CO487KShares$531,1513.54% of portfolio
-
Lion Street Advisors, LLC334KShares$363,7600.11% of portfolio
-
Envestnet Asset Management Inc329KShares$358,7720.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $67.5M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...